Treatment of Experimental Endocarditis Due to Erythromycin-Susceptible or -Resistant Methicillin-Resistant Staphylococcus Aureus With RP 59500

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.39.7.1419
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Daptomycin Is Effective in Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus Aureus

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

Clinical and Prognostic Differences Between Methicillin-Resistant and Methicillin-Susceptible Staphylococcus Aureus Infective Endocarditis

BMC Infectious Diseases
Infectious Diseases
2020English

Are Methicillin-Susceptible Staphylococcus Aureus Carriers Protected From Methicillin-Resistant Staphylococcus Aureus Infections?

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

Staphylococcus Aureus Resistant to Methicillin.

BMJ
1991English

Methicillin-Resistant Staphylococcus Aureus

The Lancet
Medicine
1974English

Methicillin Resistant Staphylococcus Aureus;

The Professional Medical Journal
2019English

Methicillin-Resistant Staphylococcus Aureus

Infection Management for Geriatrics in Long-Term Care Facilities
2006English

Methicillin-Resistant Staphylococcus Aureus

Journal of wound care
FundamentalsSkillsNursing
1998English

Methicillin-Resistant Staphylococcus Aureus

Journal of wound care
FundamentalsSkillsNursing
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy